Secondary Logo

Journal Logo

January 24, 2003 - Volume 17 - Issue 2
pp: N1-N3,147-281

Candidate HIV/AIDS vaccines: lessons learned from the World's first phase III efficacy trials

Francis, Donald P; Heyward, William L; Popovic, Vladimir; More

AIDS. 17(2):147-156, January 24, 2003.


Efficacy of a twice-daily antiretroviral regimen containing 100 mg ritonavir/400 mg indinavir in HIV-infected patients

Ghosn, Jade; Lamotte, Claire; Ait-Mohand, Hocine; More

AIDS. 17(2):209-214, January 24, 2003.

Risk factors for Kaposi's sarcoma in men seropositive for both human herpesvirus 8 and human immunodeficiency virus

Cannon, Michael J; Dollard, Sheila C; Black, Jodi B; More

AIDS. 17(2):215-222, January 24, 2003.